CTLA4-Ig enhanced glucocorticoid effect on murine asthma

A. Mori (Sagamihara, Kanagawa, Japan)

Source: International Congress 2017 – Animal models of asthma and allergies
Session: Animal models of asthma and allergies
Session type: Thematic Poster
Number: 1148
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mori (Sagamihara, Kanagawa, Japan). CTLA4-Ig enhanced glucocorticoid effect on murine asthma. 1148

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002

Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006

Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 24s
Year: 2007

Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 50s
Year: 2005

Formoterol enhances glucocorticoid receptor nuclear translocation in steroid-insensitive severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 250s
Year: 2004

A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010

Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide
Source: International Congress 2018 – Basic pharmacology
Year: 2018

Interleukin-12 receptor mRNA expression and corticosteroid depended eosinophil apoptosis in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 223s
Year: 2003

Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002

IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Long-term bortezomib treatment decreases allergen-specific IgE but fails to amend chronic asthma in mice
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012